GeneDx Holdings (WGSWW) Capital Leases (2020 - 2021)

GeneDx Holdings (WGSWW) reported Capital Leases of $18.4 million for Q4 2021, down 11.31% year-over-year from $20.8 million in Q4 2020, and down 11.31% quarter-over-quarter from $20.8 million in Q4 2020.

GeneDx Holdings (WGSWW) Capital Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGSWW) has 2 years of Capital Leases data on file, last reported at $18.4 million in Q4 2021.

  • Capital Leases for Q4 2021 came in at $18.4 million, down 11.31% year-over-year; the trailing twelve-month figure through Dec 2021 was $18.4 million (down 11.31% YoY), and the FY2021 annual result was $18.4 million, down 11.31% from the prior year.
  • Capital Leases fell to $18.4 million in Q4 2021 per WGSWW's latest filing, from $20.8 million in the prior quarter.
  • Over five years, Capital Leases peaked at $20.8 million in Q4 2020 and troughed at $18.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 GeneDx Holdings - - 68.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 18.43 Mn
Dec 31, 2020 20.78 Mn